A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine

scientific article published on 01 March 1993

A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID7682339

P2093author name stringH. Fukui
S. Terada
I. Tanaka
A. Yoshioka
H. Nakai
M. Shima
D. Scandella
S. Kamisue
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectmonoclonal antibodyQ422248
P304page(s)240-246
P577publication date1993-03-01
P1433published inThrombosis and HaemostasisQ15724413
P1476titleA factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine
P478volume69

Reverse relations

cites work (P2860)
Q36250957A major determinant of the immunogenicity of factor VIII in a murine model is independent of its procoagulant function
Q36447889Antihuman factor VIII C2 domain antibodies in hemophilia A mice recognize a functionally complex continuous spectrum of epitopes dominated by inhibitors of factor VIII activation
Q37382199B-cell and T-cell epitopes in anti-factor VIII immune responses
Q42036652Binding of blood coagulation factor VIII and its light chain to phosphatidylserine/phosphatidylcholine bilayers as measured by ellipsometry.
Q38118763Blood Clotting Factor VIII: From Evolution to Therapy
Q36742268Characterization and solution structure of the factor VIII C2 domain in a ternary complex with classical and non-classical inhibitor antibodies
Q36412125Characterization of factor VIII inhibitors
Q37626483Epitope mapping of inhibitory antibodies targeting the C2 domain of coagulation factor VIII by hydrogen-deuterium exchange mass spectrometry.
Q33918888Haemophilia A and haemophilia B: molecular insights
Q53315892Haemophilia A and haemophilia B: molecular insights.
Q36317966Highly conserved antigenic structure of the factor VIII C2 domain in some mammals.
Q43167061Identification of plasmin-interactive sites in the light chain of factor VIII responsible for proteolytic cleavage at Lys36.
Q82712834Management of factor VIII inhibitors
Q37382208Management of haemophilia A-inhibitor patients: clinical and regulatory perspectives
Q41850873Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry
Q36896861Membrane-binding properties of the Factor VIII C2 domain
Q33962546Non-classical anti-factor VIII C2 domain antibodies are pathogenic in a murine in vivo bleeding model.
Q36835121Nonclassical anti-C2 domain antibodies are present in patients with factor VIII inhibitors
Q64067191Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products
Q37129689Quantitation of anti-factor VIII antibodies in human plasma
Q80273707Relationship between the binding sites for von Willebrand factor, phospholipid, and human factor VIII C2 inhibitor alloantibodies within the factor VIII C2 domain
Q24530891Structure and topography of the membrane-binding C2 domain of factor VIII in the presence of dodecylphosphocholine micelles
Q36310238Structure of the Human Factor VIII C2 Domain in Complex with the 3E6 Inhibitory Antibody
Q27680123Structure of the factor VIII C2 domain in a ternary complex with 2 inhibitor antibodies reveals classical and nonclassical epitopes
Q35578480The 1.7 Å X-ray crystal structure of the porcine factor VIII C2 domain and binding analysis to anti-human C2 domain antibodies and phospholipid surfaces
Q35832756The important role of von Willebrand factor in platelet-derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies.
Q45866649The structural basis for the functional comparability of factor VIII and the long-acting variant recombinant factor VIII Fc fusion protein
Q37374547Varied immune response to FVIII: presence of proteolytic antibodies directed to factor VIII in different human pathologies

Search more.